Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.9 GBX | +2.58% | +2.21% | +53.59% |
May. 01 | Poolbeg Pharma Secures Full Patent in US for Immunomodulator II | MT |
May. 01 | Poolbeg Pharma celebrates full patent approval for Immunomodulator II | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+53.59% | 88.42M | |
+18.34% | 124B | |
+15.06% | 109B | |
-6.39% | 23.84B | |
+2.39% | 22.42B | |
-12.11% | 17.5B | |
-41.64% | 16.43B | |
-12.07% | 16.61B | |
+1.05% | 13.4B | |
+25.87% | 11.47B |
- Stock Market
- Equities
- POLB Stock
- News Poolbeg Pharma PLC
- Poolbeg Pharma Therapy Shows Efficacy in Lowering Cancer Immunotherapy-induced Cytokine Release Syndrome